ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Meeting News

KRYSTAL-1 Data Demonstrates Durable Adagrasib Response Against Mutated NSCLC

Fred Gebhart
on: September 26, 2023In: Meeting News, WCLC News
KRYSTAL-1 Data Demonstrates Durable Adagrasib Response Against Mutated NSCLC

After more than 2 years, the median duration of response was 12.4 months and no new safety signals were seen, according to Dr. Shirish Gadgeel, who presented the results during WCLC 2023. Read more


First-line Nivolumab + Ipilimumab Superior to Chemotherapy in Metastatic NSCLC at 6 Years

Fred Gebhart
on: September 26, 2023In: Meeting News, WCLC News
First-line Nivolumab + Ipilimumab Superior to Chemotherapy in Metastatic NSCLC at 6 Years

Dr. Solange Peters presented new follow-up data from CheckMate 227 that show positive results regardless of PD-L1 expression. Read more

Study Shows Exhaled Breath May Track Treatment Response in Mesothelioma

Fred Gebhart
on: September 26, 2023In: Meeting News, WCLC News
Study Shows Exhaled Breath May Track Treatment Response in Mesothelioma

During WCLC 2023, researcher Dr. Kevin Lamote shared data that demonstrated VOCs in exhaled breath could be a useful biomarker. Read more

IASLC’s New 5-Year Strategic Plan Unveiled at Business Meeting

Cody Holt
on: September 26, 2023In: Meeting News, WCLC News
IASLC’s New 5-Year Strategic Plan Unveiled at Business Meeting

IASLC leaders also shared highlights from the association’s membership growth and financial report and officially welcomed President Dr. Paul Van Schil. Read more

MARS2: Decortication Plus Chemotherapy Associated with Worse Outcomes for Resectable Mesothelioma

Fred Gebhart
on: September 11, 2023In: Meeting News, WCLC News
MARS2: Decortication Plus Chemotherapy Associated with Worse Outcomes for Resectable Mesothelioma

During the Presidential Plenary, investigator Dr. Eric Lim shared data comparing surgery plus chemotherapy to chemotherapy alone, one of several potentially practice-changing studies presented during the session. Read more

Studies Indicate Progress, Highlight Challenges of Combating Lung Cancer Stigma

Cody Holt
on: September 11, 2023In: Meeting News, WCLC News
Studies Indicate Progress, Highlight Challenges of Combating Lung Cancer Stigma

Data presented by patient advocate Jill Feldman and Nathan Harrison show that while the IASLC’s Language Guide is helping to reduce the use of stigmatizing language, research on the effects of stigma in lung cancer is lacking. Read more

Closing Plenary Aims to Close the Gap Between Neoadjuvant IO, Pathology

Fred Gebhart
on: September 11, 2023In: Meeting News, WCLC News
Closing Plenary Aims to Close the Gap Between Neoadjuvant IO, Pathology

Drs. Keith Kerr and Sanja Dacic will examine the role of pathology in patient selection and specimen interpretation in the era of neoadjuvant immunotherapy. Read more

Plenary Session to Offer Strategies for Overcoming Barriers in Transforming Discoveries into Treatments in Lower, Middle-Income Regions

Fred Gebhart
on: September 11, 2023In: Meeting News, WCLC News
Plenary Session to Offer Strategies for Overcoming Barriers in Transforming Discoveries into Treatments in Lower, Middle-Income Regions

Co-chair Dr. Pyng Lee said simply because a treatment has been approved does not make it an affordable and accessible clinical alternative for lung cancer patients in the real world. Read more

Successful Lung Cancer Screening Programs Must Consider Unique Needs of Region, Population

Fred Gebhart
on: September 11, 2023In: Meeting News, WCLC News
Successful Lung Cancer Screening Programs Must Consider Unique Needs of Region, Population

Drs. Claudia Henschke and Pan-Chy Yang to chair an education session designed to help thoracic oncologists translate research into successful lung cancer screening efforts. Read more

Educational Session to Provide Update on Recent Progress in Treatment of ‘Extensive-Stage’ SCLC

Fred Gebhart
on: September 11, 2023In: Meeting News, WCLC News
Educational Session to Provide Update on Recent Progress in Treatment of ‘Extensive-Stage’ SCLC

Drs. Hidehito Horinouchi and Stephen Liu will chair the session, which will explore multiple advances driving survival gains, including antibody-drug conjugates, bispecific T-cell engagers, and targeted therapies. Read more

«‹11121314151617›»

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy